Watch Product Details Video
US$ 23.11
ghk-cu fda approval status 2026 The peptide regulatory landscape in 2026 is in active flux GHK-Cu (Copper Peptide) for Lab
Description
Kojima, I
NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome
Its discovery opened a new chapter in sleep science, establishing that the brain produces discrete peptide signals capable of modulating sleep architecture a concept that has since expanded into a broader field of sleep-regulatory neuropeptide research
It does not replace medical diagnosis or treatment
